Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer: Molecular Therapy
The potential of CAR T therapy for relapsed or refractory pediatric an | TCRM
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography | Science Advances
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant | Leukemia
Cells | Free Full-Text | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE) | BMJ Open
Frankel – Chimeric Antigen Receptor T Cells-Charting the Course from Clinical Trials to Commercialization
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model: Molecular Therapy - Oncolytics
CD19-targeted CAR T cells in refractory antisynthetase syndrome - The Lancet
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
JCI - HIV-specific CAR T cells return to the clinic
Frontiers | Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells
High-Affinity CD19 for CAR-T Cell Therapy
CAR T Cells: Second-Line Treatment Option for NHL? - NCI
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus | NEJM
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis - The Lancet Haematology
CASI Pharmaceuticals | CNCT19
Overview of CD19-targeted chimeric antigen receptor (CAR)-T-cell... | Download Scientific Diagram
CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity: Molecular Therapy - Oncolytics
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) - Sarah K. Tasian, Rebecca A. Gardner, 2015
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells | PLOS ONE
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
